Achieve Life Sciences, Inc. (NASDAQ:ACHV)
| Market Cap | 736.07M+109.9% |
| Revenue (ttm) | 0 |
| Net Income | -114.04M-126.2% |
| EPS | -1.55-6.2% |
| Shares Out | 102.66M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 82,838.883 |
| Open | 7.14 |
| Previous Close | 7.24 |
| Day's Range | 7.05 - 7.19 |
| 52-Week Range | 2.62 - 8.64 |
| Beta | 2.31 |
| Analysts | Buy |
| Price Target | 14.80(+106.42%) |
| Earnings Date | Nov 5, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About ACHV
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$ACHV stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in ACHV holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ACHV's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ACHV Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ACHV patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ACHV from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ACHV
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $24.68M |
| XBIState Street SPDR S&P Biotech ETF | $15.43M |
| IWMiShares Russell 2000 ETF | $14.42M |
| VXFVanguard Extended Market ETF | $7.69M |
| SURISimplify Propel Opportunities ETF | $6.75M |
| IWOiShares Russell 2000 Growth ETF | $5.06M |
Estimated from each fund’s disclosed top holdings × AUM
ACHV Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ACHV’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score